Medical & Vaccines

Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy

The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients

Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »

After Hours: Drs Vaughn and Kory Breaking New Ground on Covid and Covid Vaccine Injuries (Podcast)

The latest must-have information from two cutting edge medical doctors on the front lines of treating thousands of Covid and Covid Vaccine injuries, Dr. Jordan Vaughn and Dr. Pierre Kory. What they’re learning that our own government isn’t telling us.

After Hours: Drs Vaughn and Kory Breaking New Ground on Covid and Covid Vaccine Injuries (Podcast) Read More »

Cutting edge treatments for ‘Long Covid/Long Vax’; Clots in cadavers; Covid exodus from establishment medicine

According to a National Institutes of Health study, as many as one in four adults who have had Covid are suffering from what they’re calling “Long Covid,” which is may also be “Long Vax” since most of those suffering were

Cutting edge treatments for ‘Long Covid/Long Vax’; Clots in cadavers; Covid exodus from establishment medicine Read More »

Scroll to Top